Teva (TEVA) Enters a New $700 Million Acquisition Deal
Summary
Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the Stocks that Billionaire Druckenmiller and Jim Cramer like. On April 29, 2026, Teva Pharmaceutic...
Original reporting
Open original sourceAFBytes is a read-only aggregator. Use the original source for full context and complete reporting.